Docusate
未知生产厂商
Docusate is a medication used to treat constipation associated with dry, hard stools, or opioid induced constipation.
Docusate is a medication used to treat constipation associated with dry, hard stools, or opioid induced constipation.
Recent studies suggest that docusate's mechanism of action is due largely to it's surfactant effect in the intestines, which allow fat and water into the feces to soften the stool. Docusate’s mechanism of action was investigated in 1985 on healthy patients. Docusate was added directly to the jejunum based on calculated concentrations of docusate in the jejunum. At this concentration, there was an increase in secretion of water, sodium, chloride, and potassium as well as a decrease in absorption of glucose and bicarbonate. Based on in vitro data, the authors suggested this effect was due to an increase in intracellular cyclic AMP either directly through docusate or E series prostaglandins.
Indicated for the treatment of constipation associated with dry, hard stools or opioid induced constipation. Though recently, pressure has been building to end the use of docusate over concerns of efficacy.
共 2 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。